TaiMed Biologics Inc. (TPEX:4147)

TaiMed Biologics Revenue

TaiMed Biologics had revenue of 166.08M TWD in the quarter ending March 31, 2026, a decrease of -5.76%. This brings the company's revenue in the last twelve months to 601.19M, down -1.03% year-over-year. In the year 2025, TaiMed Biologics had annual revenue of 611.35M with 0.19% growth.

• Revenue (ttm): 601.19M
• Revenue Growth: -1.03%
• P/S Ratio: 25.99
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	611.35M	1.19M	0.19%
Dec 31, 2024	610.16M	118.39M	24.07%
Dec 31, 2023	491.78M	-71.23M	-12.65%
Dec 31, 2022	563.01M	149.57M	36.18%
Dec 31, 2021	413.44M	-309.04M	-42.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error